1. Home
  2. QTTB vs RCON Comparison

QTTB vs RCON Comparison

Compare QTTB & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.82

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

HOLD

Current Price

$1.14

Market Cap

34.9M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
RCON
Founded
2015
2007
Country
United States
China
Employees
N/A
188
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
34.9M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
QTTB
RCON
Price
$6.82
$1.14
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
177.3K
69.7K
Earning Date
06-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
136.78
N/A
EPS
2.42
N/A
Revenue
$53,737,000.00
$6,430,788.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.91
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$1.13
52 Week High
$7.65
$7.16

Technical Indicators

Market Signals
Indicator
QTTB
RCON
Relative Strength Index (RSI) 76.03 42.21
Support Level $3.75 N/A
Resistance Level N/A $1.56
Average True Range (ATR) 0.60 0.20
MACD 0.24 -0.02
Stochastic Oscillator 73.55 7.03

Price Performance

Historical Comparison
QTTB
RCON

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

Share on Social Networks: